Use of a gene-based pigmented lesion assay (PLA) may result in fewer biopsies for benign lesions and greater accuracy in identifying melanomas, researchers say.Reuters Health Information http://ift.tt/2qJvmN6
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου